Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Lim RP, Qassin S, McKenna L, Hornsey E, Italiano D, Churilov L, MacIsaac RJ, Seah JM, Ekinci EI, Austin EMPA‐MRI Study Group

Open source

DOI
10.1111/dom.70950
Published
2026 Aug
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.70950,
  title = {Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.},
  author = {Lim RP and Qassin S and McKenna L and Hornsey E and Italiano D and Churilov L and MacIsaac RJ and Seah JM and Ekinci EI and Austin EMPA‐MRI Study Group},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70950},
  url = {https://doi.org/10.1111/dom.70950}
}

RIS

TY  - JOUR
TI  - Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.
AU  - Lim RP
AU  - Qassin S
AU  - McKenna L
AU  - Hornsey E
AU  - Italiano D
AU  - Churilov L
AU  - MacIsaac RJ
AU  - Seah JM
AU  - Ekinci EI
AU  - Austin EMPA‐MRI Study Group
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70950
UR  - https://doi.org/10.1111/dom.70950
ER  - 

APA

RP, L., S, Q., L, M., E, H., D, I., L, C., RJ, M., JM, S., EI, E., & Group, A. E. S. (2026). Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70950

Source records